The rationale for designing cancer vaccines is similar to that of vaccines against infectious diseases [240], which can be summarized as employing disease/tumor associated specific antigens to elicit APC mediated CD8+ and CD4+ T cell responses [242] and induce a persistent immune memory [243]. Here, CD8A is linked to neoplasm.